J. Ruby

Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States

V. Zah, C. Asche, E. Clay, 2015, Journal of medical economics.

Recommendations for estrogen and progestin replacement in the climacteric and postmenopause. European Progestin Club.

C. Campagnoli, A. Schindler, J. Thijssen, 1999, Maturitas.

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis

V. Zah, D. Vukicevic, J. Ruby, 2020, ClinicoEconomics and outcomes research : CEOR.

CEOR_A_269957 635..643

V. Zah, D. Vukicevic, J. Ruby, 2020 .

Analysis of Buprenorphine/Naloxone Dosing Impact on Treatment Duration, Resource Use and Costs in the Treatment of Opioid-Dependent Adults: A Retrospective Study of US Public and Private Health Care Claims

V. Zah, M. Toumi, E. Kharitonova, 2014, Postgraduate medicine.

Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy

V. Zah, Filip Stanicic, D. Vukicevic, 2022, Plastic and Reconstructive Surgery, Global Open.

Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence

V. Zah, C. Asche, E. Clay, 2014, Journal of medical economics.